CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

EKR Therapeutics, Inc.

EKR Therapeutics, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bedminster, NJ. To find more information about EKR Therapeutics, Inc., please visit www.ekrtx.com

BioAbility

BioAbility is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Helicos BioSciences

Helicos BioSciences Corporation is developing instruments for ultra-high-throughput sequencing of DNA or RNA without amplification.

Vista Del Mar Child and Family Services

Vista Del Mar Child and Family Services is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedClean Technologies

MedClean Technologies is a Bethel, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.